Recombinant Activated Protein C Treatment Improves Tissue Perfusion and Oxygenation in Septic Patients Measured by Near-infrared Spectroscopy

Overview

Journal Crit Care

Specialty Critical Care

Date 2009 Dec 3

PMID 19951384

Citations 13

Authors

Abele Donati

Michela Romanelli

Laura Botticelli

Agnese Valentini

Vincenzo Gabbanelli

Simonetta Nataloni

Tiziana Principi

Paolo Pelaia

Rick Bezemer

Can Ince

Affiliations

Soon will be listed here.

Abstract

Introduction: The purpose was to test the hypothesis that muscle perfusion, oxygenation, and microvascular reactivity would improve in patients with severe sepsis or septic shock during treatment with recombinant activated protein C (rh-aPC) (n = 11) and to explore whether these parameters are related to macrohemodynamic indices, metabolic status or Sequential Organ Failure Assessment (SOFA) score. Patients with contraindications to rh-aPC were used as a control group (n = 5).

Materials And Methods: Patients were sedated, intubated, mechanically ventilated, and hemodynamically monitored with the PiCCO system. Tissue oxygen saturation (StO2) was measured using near-infrared spectroscopy (NIRS) during the vascular occlusion test (VOT). Baseline StO2 (StO2 baseline), rate of decrease in StO2 during VOT (StO2 downslope), and rate of increase in StO2 during the reperfusion phase were (StO2 upslope) determined. Data were collected before (T0), during (24 hours (T1a), 48 hours (T1b), 72 hours (T1c) and 96 hours (T1d)) and 6 hours after stopping rh-aPC treatment (T2) and at the same times in the controls. At every assessment, hemodynamic and metabolic parameters were registered and the SOFA score calculated.

Results: The mean +/- standard deviation Acute Physiology and Chronic Health Evaluation II score was 26.3 +/- 6.6 and 28.6 +/- 5.3 in rh-aPC and control groups, respectively. There were no significant differences in macrohemodynamic parameters between the groups at all the time points. In the rh-aPC group, base excess was corrected (P < 0.01) from T1a until T2, and blood lactate was significantly decreased at T1d and T2 (2.8 +/- 1.3 vs. 1.9 +/- 0.7 mmol/l; P < 0.05). In the control group, base excess was significantly corrected at T1a, T1b, T1c, and T2 (P < 0.05). The SOFA score was significantly lower in the rh-aPC group compared with the controls at T2 (7.9 +/- 2.2 vs. 12.2 +/- 3.2; P < 0.05). There were no differences between groups in StO2 baseline. StO2 downslope in the rh-aPC group decreased significantly at all the time points, and at T1b and T2 (-16.5 +/- 11.8 vs. -8.1 +/- 2.4%/minute) was significantly steeper than in the control group. StO2 upslope increased and was higher than in the control group at T1c, T1d and T2 (101.1 +/- 62.1 vs. 54.5 +/- 23.8%/minute) (P < 0.05).

Conclusions: Treatment with rh-aPC may improve muscle oxygenation (StO2 baseline) and reperfusion (StO2 upslope) and, furthermore, rh-aPC treatment may increase tissue metabolism (StO2 downslope). NIRS is a simple, real-time, non-invasive technique that could be used to monitor the effects of rh-aPC therapy at microcirculatory level in septic patients.

Citing Articles

Microcirculation-guided resuscitation in sepsis: the next frontier?.

Damiani E, Carsetti A, Casarotta E, Domizi R, Scorcella C, Donati A Front Med (Lausanne). 2023; 10:1212321.

PMID: 37476612 PMC: 10354242. DOI: 10.3389/fmed.2023.1212321.

Down-regulation of Xist and Mir-7a-5p improves LPS-induced myocardial injury.

Liang D, Jin Y, Lin M, Xia X, Chen X, Huang A Int J Med Sci. 2020; 17(16):2570-2577.

PMID: 33029099 PMC: 7532474. DOI: 10.7150/ijms.45408.

Near-infrared spectroscopy for assessing tissue oxygenation and microvascular reactivity in critically ill patients: a prospective observational study.

Donati A, Damiani E, Domizi R, Scorcella C, Carsetti A, Tondi S Crit Care. 2016; 20(1):311.

PMID: 27716370 PMC: 5045573. DOI: 10.1186/s13054-016-1500-5.

Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis.

Damiani E, Adrario E, Luchetti M, Scorcella C, Carsetti A, Mininno N PLoS One. 2015; 10(5):e0122655.

PMID: 25932999 PMC: 4416810. DOI: 10.1371/journal.pone.0122655.

Comparison of two devices using near-infrared spectroscopy for the measurement of tissue oxygenation during a vascular occlusion test in healthy volunteers (INVOS® vs. InSpectra™).

Lee J, Park Y, Kim H, Kim J J Clin Monit Comput. 2014; 29(2):271-8.

PMID: 25005912 DOI: 10.1007/s10877-014-9595-1.

References

Gierer P, Hoffmann J, Mahr F, Menger M, Mittlmeier T, Gradl G . Activated protein C reduces tissue hypoxia, inflammation, and apoptosis in traumatized skeletal muscle during endotoxemia. Crit Care Med. 2007; 35(8):1966-71. DOI: 10.1097/01.CCM.0000275270.14835.2A. View

Spronk P, Ince C, Gardien M, Mathura K, Oudemans-van Straaten H, Zandstra D . Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet. 2002; 360(9343):1395-6. DOI: 10.1016/s0140-6736(02)11393-6. View

De Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent J . Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med. 2006; 34(7):1918-24. DOI: 10.1097/01.CCM.0000220498.48773.3C. View

Yamaji K, Wang Y, Liu Y, Abeyama K, Hashiguchi T, Uchimura T . Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. Thromb Res. 2005; 115(4):319-25. DOI: 10.1016/j.thromres.2004.09.011. View

Macias W, Yan S, Williams M, Um S, Sandusky G, Ballard D . New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). Crit Care. 2005; 9 Suppl 4:S38-45. PMC: 3226161. DOI: 10.1186/cc3747. View

Jhanji S, Stirling S, Patel N, Hinds C, Pearse R . The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med. 2009; 37(6):1961-6. DOI: 10.1097/CCM.0b013e3181a00a1c. View

Pareznik R, Knezevic R, Voga G, Podbregar M . Changes in muscle tissue oxygenation during stagnant ischemia in septic patients. Intensive Care Med. 2005; 32(1):87-92. DOI: 10.1007/s00134-005-2841-8. View

Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A . Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation. 2001; 104(10):1171-5. DOI: 10.1161/hc3501.093799. View

Boushel R, Langberg H, Olesen J, Bulow J, Kjaer M . Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports. 2001; 11(4):213-22. DOI: 10.1034/j.1600-0838.2001.110404.x. View

10.

Vincent J, Bernard G, Beale R, Doig C, Putensen C, Dhainaut J . Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med. 2005; 33(10):2266-77. DOI: 10.1097/01.ccm.0000181729.46010.83. View

11.

Dellinger R, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J . Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32(3):858-73. DOI: 10.1097/01.ccm.0000117317.18092.e4. View

12.

De Backer D, Creteur J, Preiser J, Dubois M, Vincent J . Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002; 166(1):98-104. DOI: 10.1164/rccm.200109-016oc. View

13.

Doerschug K, Delsing A, Schmidt G, Haynes W . Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol. 2007; 293(2):H1065-71. DOI: 10.1152/ajpheart.01237.2006. View

14.

Creteur J, Carollo T, Soldati G, Buchele G, De Backer D, Vincent J . The prognostic value of muscle StO2 in septic patients. Intensive Care Med. 2007; 33(9):1549-56. DOI: 10.1007/s00134-007-0739-3. View

15.

Skarda D, Mulier K, Myers D, Taylor J, Beilman G . Dynamic near-infrared spectroscopy measurements in patients with severe sepsis. Shock. 2007; 27(4):348-53. DOI: 10.1097/01.shk.0000239779.25775.e4. View

16.

De Blasi R, Palmisani S, Alampi D, Mercieri M, Romano R, Collini S . Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock. Intensive Care Med. 2005; 31(12):1661-8. DOI: 10.1007/s00134-005-2822-y. View

17.

Knotzer H, Pajk W, Dunser M, Maier S, Mayr A, Ritsch N . Regional microvascular function and vascular reactivity in patients with different degrees of multiple organ dysfunction syndrome. Anesth Analg. 2006; 102(4):1187-93. DOI: 10.1213/01.ane.0000198587.10553.c1. View

18.

Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B . Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock. 2008; 29(5):572-6. DOI: 10.1097/SHK.0b013e318157e926. View

19.

Bernard G, Vincent J, Laterre P, LaRosa S, Dhainaut J, Lopez-Rodriguez A . Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001; 344(10):699-709. DOI: 10.1056/NEJM200103083441001. View

20.

Ince C . The microcirculation is the motor of sepsis. Crit Care. 2005; 9 Suppl 4:S13-9. PMC: 3226164. DOI: 10.1186/cc3753. View